These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

589 related items for PubMed ID: 26510598

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
    Blaschke S, Hannig H, Buske C, Kaup FJ, Hunsmann G, Bodemer W.
    J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential.
    Ma SD, Tsai MH, Romero-Masters JC, Ranheim EA, Huebner SM, Bristol JA, Delecluse HJ, Kenney SC.
    J Virol; 2017 Apr 01; 91(7):. PubMed ID: 28077657
    [Abstract] [Full Text] [Related]

  • 46. Epstein-Barr virus strains defined by the latent membrane protein 1 sequence characterize Thai ethnic groups.
    Saechan V, Settheetham-Ishida W, Kimura R, Tiwawech D, Mitarnun W, Ishida T.
    J Gen Virol; 2010 Aug 01; 91(Pt 8):2054-2061. PubMed ID: 20427564
    [Abstract] [Full Text] [Related]

  • 47. Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line.
    Szekely L, Chen F, Teramoto N, Ehlin-Henriksson B, Pokrovskaja K, Szeles A, Manneborg-Sandlund A, Löwbeer M, Lennette ET, Klein G.
    J Gen Virol; 1998 Jun 01; 79 ( Pt 6)():1445-52. PubMed ID: 9634087
    [Abstract] [Full Text] [Related]

  • 48. Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders.
    Scheinfeld AG, Nador RG, Cesarman E, Chadburn A, Knowles DM.
    Am J Pathol; 1997 Sep 01; 151(3):805-12. PubMed ID: 9284829
    [Abstract] [Full Text] [Related]

  • 49. Epstein-Barr virus latent membrane protein 1 genetic variability in peripheral blood B cells and oropharyngeal fluids.
    Renzette N, Somasundaran M, Brewster F, Coderre J, Weiss ER, McManus M, Greenough T, Tabak B, Garber M, Kowalik TF, Luzuriaga K.
    J Virol; 2014 Apr 01; 88(7):3744-55. PubMed ID: 24429365
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. The vIL-10 gene of the Epstein-Barr virus (EBV) is conserved in a stable manner except for a few point mutations in various EBV isolates.
    Kanai K, Satoh Y, Yamanaka H, Kawaguchi A, Horie K, Sugata K, Hoshikawa Y, Sata T, Sairenji T.
    Virus Genes; 2007 Dec 01; 35(3):563-9. PubMed ID: 17763933
    [Abstract] [Full Text] [Related]

  • 52. Dysregulation of Dual-Specificity Phosphatases by Epstein-Barr Virus LMP1 and Its Impact on Lymphoblastoid Cell Line Survival.
    Lin KM, Lin SJ, Lin JH, Lin PY, Teng PL, Wu HE, Yeh TH, Wang YP, Chen MR, Tsai CH.
    J Virol; 2020 Jan 31; 94(4):. PubMed ID: 31776277
    [Abstract] [Full Text] [Related]

  • 53. Interleukin-21 regulates expression of key Epstein-Barr virus oncoproteins, EBNA2 and LMP1, in infected human B cells.
    Konforte D, Simard N, Paige CJ.
    Virology; 2008 Apr 25; 374(1):100-13. PubMed ID: 18222514
    [Abstract] [Full Text] [Related]

  • 54. Are particular Epstein-Barr virus strains linked to disease?
    Jenkins PJ, Farrell PJ.
    Semin Cancer Biol; 1996 Aug 25; 7(4):209-15. PubMed ID: 8946605
    [Abstract] [Full Text] [Related]

  • 55. Selection pressure-driven evolution of the Epstein-Barr virus-encoded oncogene LMP1 in virus isolates from Southeast Asia.
    Burrows JM, Bromham L, Woolfit M, Piganeau G, Tellam J, Connolly G, Webb N, Poulsen L, Cooper L, Burrows SR, Moss DJ, Haryana SM, Ng M, Nicholls JM, Khanna R.
    J Virol; 2004 Jul 25; 78(13):7131-7. PubMed ID: 15194789
    [Abstract] [Full Text] [Related]

  • 56. Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.
    Tao Y, Shi Y, Jia J, Jiang Y, Yang L, Cao Y.
    Expert Rev Mol Med; 2015 Aug 18; 17():e15. PubMed ID: 26282825
    [Abstract] [Full Text] [Related]

  • 57. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL, Zong YS, Lin SX, Zhang M, Liang YJ.
    Ai Zheng; 2006 Feb 18; 25(2):136-42. PubMed ID: 16480574
    [Abstract] [Full Text] [Related]

  • 58. Mutational events in LMP1 gene of Epstein-Barr virus in salivary gland lymphoepithelial carcinomas.
    Jen KY, Cheng J, Li J, Wu L, Li Y, Yu S, Lin H, Chen Z, Gurtsevitch V, Saku T.
    Int J Cancer; 2003 Jul 10; 105(5):654-60. PubMed ID: 12740914
    [Abstract] [Full Text] [Related]

  • 59. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
    Meij P, Vervoort MB, Aarbiou J, van Dissel P, Brink A, Bloemena E, Meijer CJ, Middeldorp JM.
    J Infect Dis; 1999 May 10; 179(5):1108-15. PubMed ID: 10191211
    [Abstract] [Full Text] [Related]

  • 60. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis.
    Peng M, Lundgren E.
    Oncogene; 1992 Sep 10; 7(9):1775-82. PubMed ID: 1354347
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.